Stéphanie Corgnac

8PUBLICATIONS
25CO-AUTHORS
Molecular targetsTumour immunologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 23, 2026
VEGF-A blockade overcomes liver metastases resistance to chemoimmunotherapy in patients with advanced non-squamous NSCLC.

|Jul 02, 2025
Different tumour-resident memory T-cell subsets regulate responses to anti-PD-1 and anti-CTLA-4 cancer immunotherapies.

Isabelle Damei, Aziza Caidi, Edouard Auclin

|Apr 29, 2024
Sepsis-trained macrophages promote antitumoral tissue-resident T cells.

Alexis Broquet, Victor Gourain, Thomas Goronflot

|Jan 19, 2023
Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises.

Mohamad Omar Ashi, Fathia Mami-Chouaib, Stéphanie Corgnac

|Sep 02, 2021
Integrin-αV-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade.

Ines Malenica, Julien Adam, Stéphanie Corgnac

|Jul 28, 2019
Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1.

Marine Leclerc, Elodie Voilin, Gwendoline Gros

Pageof 2

Frequent Collaborators

5 joint publications

Fathia Mami-Chouaib

2 joint publications

Christelle Harly

2 joint publications

Vincent de Montpréville

2 joint publications

Eric Tartour